AFWM
ARCT icon

Abich Financial Wealth Management’s Arcturus Therapeutics ARCT Stock Holding History

Abich Financial Wealth Management’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$2.67K Buy
115
+84
+271% +$1.8K 0.01% 316
2024
Q2 		$755 Buy
31
+28
+933% +$849 ﹤0.01% 663
2024
Q1 		$101 Buy
+3
New +$106 ﹤0.01% 523

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Abich Financial Wealth Management's ARCT Position: Q3 2024 in Review

Abich Financial Wealth Management increased its Arcturus Therapeutics (ARCT) stake by 271% in Q3 2024, buying an estimated $1.8K and bringing the position to 115 shares worth $2.67K. The position accounts for 0.01% of the portfolio, ranked #316.

Abich Financial Wealth Management first reported a position in ARCT in Q1 2024 and has held it in 3 quarters since. 164 funds tracked by Wall St. Rank hold ARCT as of Q3 2024.

  • Abich Financial Wealth Management held 115 shares of Arcturus Therapeutics worth $2.67K as of Q3 2024.
  • Abich Financial Wealth Management bought 84 Arcturus Therapeutics shares in Q3 2024, an estimated $1.8K.
  • Arcturus Therapeutics made up 0.01% of Abich Financial Wealth Management's portfolio in Q3 2024, its #316 holding.
  • Abich Financial Wealth Management first reported a position in Arcturus Therapeutics in Q1 2024 and has held it in 3 quarters since.
  • 164 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2024.

Based on Abich Financial Wealth Management's 13F filing for Q3 2024, filed 25 Oct 2024.